Animal models for an enzymic blood-brain barrier mechanism for therapeutically administered L-dopa.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001921:Brain / Q000378:metabolism*; D002196:Capillaries / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002415:Cats; D002421:Caudate Nucleus / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002531:Cerebellum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D002560:Cerebrovascular Circulation / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D005260:Female; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D008856:Microscopy, Fluorescence; D009526:Nialamide / Q000494:pharmacology; D051381:Rats
D004295:Dihydroxyphenylalanine; D009526:Nialamide